Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease
Authors:
- Jeff V. SteinbrunnerJSJeff V. Steinbrunner
- Allen H. MacKenzieAMAllen H. MacKenzie
- John D. CloughJCJohn D. Clough
- Williams S. WilkeWWWilliams S. Wilke
- Allen M. SegalASAllen M. Segal
- 1 June 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 88 (6) , 589-592
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The effect of folic acid supplementation on the toxicity of low‐dose methotrexate in patients with rheumatoid arthritisArthritis & Rheumatism, 1990
- Antirheumatic Drug Treatment During Pregnancy and LactationScandinavian Journal of Rheumatology, 1985
- Pregnancy outcome following cancer chemotherapyThe American Journal of Medicine, 1980
- Drugs and PregnancyClinical Toxicology, 1978
- Methotrexate in Young Women with PsoriasisNew England Journal of Medicine, 1971
- Methotrexate-induced congenital malformationsThe Journal of Pediatrics, 1968
- Aminopterin-Induced Fetal MalformationAmerican Journal of Diseases of Children, 1968
- CYTOTOXIC DRUGS IN PREGNANCYBJOG: An International Journal of Obstetrics & Gynaecology, 1968
- Attempted Abortion with Aminopterin (4-Amino-Pteroylglutamic Acid)A.M.A. Journal of Diseases of Children, 1959
- CONGENITAL ANOMALIES DUE TO ATTEMPTED ABORTION WITH 4-AMINOPTEROGLUTAMIC ACIDJAMA, 1956